PREDICTION OF CLINICAL COURSE AND BIOLOGIC BEHAVIOR OF THE BONE GIANT CELL TUMOR USING BAX AND BCL-2 MARKERS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KHOUEI A.R.; GHARAHDAGHI M.; ATAEI R.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN JOURNAL OF PATHOLOGY (IJP) Year:2010 | Volume:5 | Issue:2 Page(s): 53-59

Download Full-Text

View:

506

Download:

109

Cites:

Information Journal Paper

Title

PREDICTION OF CLINICAL COURSE AND BIOLOGIC BEHAVIOR OF THE BONE GIANT CELL TUMOR USING BAX AND BCL-2 MARKERS

Author(s)

KHOUEI A.R. | GHARAHDAGHI M. | ATAEI R. | Issue Writer Certificate

Keywords

GIANT CELL TUMOR

BAX PROTEIN

C-BCL-2 PROTEINS

PROGNOSIS

Abstract

Background and Objectives: GIANT CELL TUMOR of bone (GCT) is often regarded as a benign tumor, but its clinical course is unpredictable, has a high rate of recurrence, and even can metastases and transform to a malignant tumor. Histological features of the tumor often could not predict its future biologic behavior, so it is just called ''GIANT CELL TUMOR'' without indicating malignancy or benignicity. Several methods are suggested to predict the biologic behavior of this tumor. This study evaluated the relation between Bax & bcl-2 as proteins involved in cell proliferation and death (apoptosis) with histopathologic features and clinical course of GCT.Materials & Methods: Paraffin- embedded tissue specimens of 40 GCTs of conventional, aggressive, recurrent, malignant, & metastatic types were evaluated by immunohistochemistry for Bax & bcl-2 markers. Clinicopathologic features and immunohistochemical results were statistically analyzed and presented in tables & diagrams. Results: Age, sex, and pattern of skeletal involvement were the same as other worldwide reports. Expression of Bax & bcl-2 markers were significantly higher in malignant GCTs but no statistically significant difference was found in other subtypes for bcl-2 while there was statistically significant difference between subgroups for Bax. Conclusion: Considerable expression of Bax & bcl-2 markers in a GCT could signal its malignant course, but low expression is not valuable in predicting the clinical course. In addition, it seems that secondary tumor nodules in lung are just simple implantation not true malignant metastases.

Cites

No record.

References

Cite

APA: Copy

KHOUEI, A.R., GHARAHDAGHI, M., & ATAEI, R.. (2010). PREDICTION OF CLINICAL COURSE AND BIOLOGIC BEHAVIOR OF THE BONE GIANT CELL TUMOR USING BAX AND BCL-2 MARKERS. IRANIAN JOURNAL OF PATHOLOGY (IJP), 5(2), 53-59. SID. https://sid.ir/paper/563320/en

Vancouver: Copy

KHOUEI A.R., GHARAHDAGHI M., ATAEI R.. PREDICTION OF CLINICAL COURSE AND BIOLOGIC BEHAVIOR OF THE BONE GIANT CELL TUMOR USING BAX AND BCL-2 MARKERS. IRANIAN JOURNAL OF PATHOLOGY (IJP)[Internet]. 2010;5(2):53-59. Available from: https://sid.ir/paper/563320/en

IEEE: Copy

A.R. KHOUEI, M. GHARAHDAGHI, and R. ATAEI, “PREDICTION OF CLINICAL COURSE AND BIOLOGIC BEHAVIOR OF THE BONE GIANT CELL TUMOR USING BAX AND BCL-2 MARKERS,” IRANIAN JOURNAL OF PATHOLOGY (IJP), vol. 5, no. 2, pp. 53–59, 2010, [Online]. Available: https://sid.ir/paper/563320/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops